Milan, Italy

Raffaele De Francesco

This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Antios Therapeutics, Inc., Istituto Nazionale Genetica Molecolare - Ingm, Ospedale San Raffaele S.r.l.. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raffaele De Francesco. Retrieved from https://idiyas.com/inventor/raffaele-de-francesco-j4k3g16c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0


Average Co-Inventor Count = 11.7

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Raffaele De Francesco: Pioneering Inventor from Milan

Introduction: Raffaele De Francesco is a distinguished inventor hailing from Milan, Italy, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: De Francesco's recent patents include advancements in renewable energy technologies, medical devices, and sustainable materials, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, De Francesco has established himself as a leading figure in the innovation landscape, with numerous patents granted globally for his inventive solutions.

Collaborations: Throughout his career, De Francesco has collaborated with top research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge exchange.

Conclusion: Raffaele De Francesco's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…